NorthWest Biotherapeutics Inc (NWBO)

[AngeloFoca]

It seems like Linda is hell bent on keeping the whole pie, but I think that in her best interest, and all present shareholders she should carve out a portion of it and learn to share.

This is what I would like to see BEFORE any further dilution, particularly if there needs to be warrants granted.

GBM is a worldwide malice and the need for an effective treatment is probably as great ex US and Europe - so why not carve out a piece of the pie for a major Asian oncology pharma.

My suggestion -
~A $500 Million deal for DC VaxL broken down as follows:
~$100 Million up front - like right NOW (that would minimize if not eliminate dilution)
~$100 Million on FDA approval of DC VaxL for GBM
~$100 Million each on FDA approval for any 3 additional cancer indications utilizing DC VaxL for operable tumors
~10% to 15% of GROSS revenues up to aggregate $1 Billion - 20% of GROSS thereafter
~Partner would be given full access to NWBO generated data, but would self-pay for any future developments
~Right of first refusal for any future partnership of DC Vax Direct

That would send the shorts scurrying - Short squeeze the hell out of them.

ps - royalty recentages would be debatable - not much else would be.